Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Olympus ( (JP:7733) ).
Olympus Corporation reported its financial results for the nine months ending December 31, 2024, showing an 8.6% increase in revenue to ¥725,221 million. The company experienced significant growth in operating profit, up 186.4%, and adjusted operating profit, up 16.4%, despite a 67.6% decline in overall profit due to the classification of its Orthopedic Business as a discontinued operation. These changes indicate a strategic shift to focus on core operations, likely impacting Olympus’s industry positioning and potentially influencing stakeholder expectations.
More about Olympus
Olympus Corporation operates in the precision and imaging industry, focusing on manufacturing optical and digital solutions. Its primary products include medical, scientific, and imaging equipment, with a significant market presence in the medical sector.
YTD Price Performance: -10.75%
Average Trading Volume: 4,233
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $16.87B
Learn more about 7733 stock on TipRanks’ Stock Analysis page.
